New data from the BEST-MSU study suggest that mobile stroke unit (MSU) care is superior to standard emergency medical services (EMS) in patients with large vessel occlusion (LVO).
Previous studies have shown that treatment with tissue plasminogen activator (tPA) in an MSU results in better clinical outcomes than standard management by EMS. However, the impact of MSU care specifically in patients with LVOs has not been established.